Target Validation Information
Target ID T89697
Target Name Indoleamine 2,3-dioxygenase
Target Type
Successful
Drug Potency against Target S-Benzyl-brassinin Drug Info Ki = 13220 nM [527977]
Seco-exiguamine Drug Info Ki = 80 nM [529627]
EXIGUAMINE B Drug Info Ki = 80 nM [529627]
2-hydroxygarveatin E Drug Info Ki = 1400 nM [528499]
Garveatin E Drug Info Ki = 3100 nM [528499]
Garveatin C Drug Info Ki = 1200 nM [528499]
ANNULIN A Drug Info Ki = 690 nM [528499]
GARVEATIN A Drug Info Ki = 3200 nM [528499]
JUGLONE Drug Info IC50 = 1000 nM [529353]
2-methoxy-1,4-naphthoquinone Drug Info IC50 = 720 nM [529353]
S-(3,4-Dichlorobenzyl)isothiourea hydrochloride Drug Info IC50 = 7300 nM [531087]
4-(tert-butylamino)naphthalen-1-ol Drug Info IC50 = 4000 nM [530623]
ANNULIN B Drug Info Ki = 120 nM [528499]
4-methoxynaphthalen-1-amine Drug Info IC50 = 5500 nM [530623]
5-aminoquinolin-8-ol Drug Info IC50 = 1000 nM [530623]
4-(methylamino)naphthalen-1-ol Drug Info IC50 = 12500 nM [530623]
2,3-dihydrobenzo[d]thiazole-2-thiol Drug Info IC50 = 7000 nM [530623]
4-Methoxybenzenemethanethiol Drug Info IC50 = 9400 nM [531087]
5-phenyl-1H-1,2,3-triazole Drug Info IC50 = 5000 nM [530623]
S-(3-Chlorobenzyl)isothiourea hydrochloride Drug Info IC50 = 1400 nM [531087]
3,4-Dichlorobenzenemethanethiol Drug Info IC50 = 1100 nM [531087]
S-(4-Bromobenzyl)isothiourea hydrobromide Drug Info IC50 = 800 nM [531087]
Naphthalene-1,4-diol Drug Info IC50 = 10000 nM [530623]
4-(Isopropylamino)-1-naphthol Drug Info IC50 = 12500 nM [530623]
5-(isopropylamino)quinolin-8-ol Drug Info IC50 = 15000 nM [530623]
4-(ethylamino)naphthalen-1-ol Drug Info IC50 = 16000 nM [530623]
4-aminonaphthalen-1-ol Drug Info IC50 = 6000 nM [530623]
4-(Benzylamino)-1-naphthol Drug Info IC50 = 2500 nM [530623]
S-(4-Ethylbenzyl)isothiourea hydrochloride Drug Info IC50 = 2500 nM [531087]
S-(2,4-Dichlorobenzyl)isothiourea hydrobromide Drug Info IC50 = 1100 nM [531087]
2,2-dimethyl-2H-benzo[g]chromene-5,10-dione Drug Info IC50 = 214 nM [529353]
2-(1H-Imidazol-4-yl)phenol Drug Info Ki = 8900 nM [529619]
4-Phenylimidazole Drug Info Ki = 4400 nM [529619]
4-(2-Hydroxyethoxy)-1-naphthol Drug Info IC50 = 12500 nM [530623]
4-(Cyclohexylamino)-1-naphthol Drug Info IC50 = 15000 nM [530623]
4-(2-(diethylamino)ethylamino)-1-naphthol Drug Info IC50 = 3000 nM [530623]
S-(4-Methoxybenzyl)isothiourea hydrochloride Drug Info IC50 = 10000 nM [531087]
4-(1H-1,2,3-triazol-5-yl)pyridine Drug Info IC50 = 5000 nM [530623]
2-Chlorobenzenemethanethiol Drug Info IC50 = 15000 nM [531087]
S-(4-Fluorobenzyl)isothiourea hydrochloride Drug Info IC50 = 2000 nM [531087]
S-(4-Methylbenzyl)isothiourea hydrochloride Drug Info IC50 = 6800 nM [531087]
BENZENEMETHANETHIOL Drug Info IC50 = 13000 nM [531087]
S-(4-Cyanobenzyl)isothiourea hydrobromide Drug Info IC50 = 2600 nM [531087]
4-Chlorobenzenemethanethiol Drug Info IC50 = 1100 nM [531087]
S-(4-Nitrobenzyl)isothiourea hydrochloride Drug Info IC50 = 2200 nM [531087]
2,4-Dichlorobenzenemethanethiol Drug Info IC50 = 4600 nM [531087]
4-Fluorobenzenemethanethiol Drug Info IC50 = 1900 nM [531087]
1H-indole-4,7-dione Drug Info Ki = 190 nM [529405]
3-(1H-Imidazol-4-yl)benzenethiol Drug Info Ki = 5300 nM [529619]
2-(1H-Imidazol-4-yl)benzene-1,3-diol Drug Info IC50 = 5300 nM [529619]
ANNULIN C Drug Info Ki = 140 nM [528499]
S-(2-Chlorobenzyl)isothiourea hydrochloride Drug Info IC50 = 4800 nM [531087]
Exiguamine A Drug Info Ki = 41 nM [529405]
4-Methylbenzenemethanethiol Drug Info IC50 = 6500 nM [531087]
1,4-naphtho-quinone Drug Info IC50 = 990 nM [529353]
4-phenylthiazole-2-thiol Drug Info IC50 = 4000 nM [530623]
3-(4H-Imidazol-4-yl)benzenethiol Drug Info Ki = 4800 nM [529619]
N-[2-(Indol-3-yl)ethyl]-S-benzyl-dithiocarbamate Drug Info Ki = 17150 nM [527977]
NLG8189 Drug Info Ki = 6600 nM [528499]
S-(4-Chlorobenzyl)isothiourea hydrochloride Drug Info IC50 = 600 nM [531087]
4-amino-1,2,5-oxadiazole-3-carboximidamide Drug Info IC50 = 1000 nM [530194]
4-(propylamino)naphthalen-1-ol Drug Info IC50 = 4500 nM [530623]
4-(Pent-3-ylamino)-1-naphthol Drug Info IC50 = 3500 nM [530623]
2,3-dichloro-1,4-naphthoquinone Drug Info IC50 = 280 nM [529353]
1,2-NAPHTHOQUINONE Drug Info IC50 = 7100 nM [529353]
2-HYDROXYGARVIN A Drug Info Ki = 2300 nM [528499]
References
Ref 527977J Med Chem. 2006 Jan 26;49(2):684-92.Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors.
Ref 529627Nat Chem Biol. 2008 Sep;4(9):535-7.Biomimetic synthesis of the IDO inhibitors exiguamine A and B.
Ref 529627Nat Chem Biol. 2008 Sep;4(9):535-7.Biomimetic synthesis of the IDO inhibitors exiguamine A and B.
Ref 528499J Nat Prod. 2006 Oct;69(10):1496-9.Indoleamine 2,3-dioxygenase inhibitors from the Northeastern Pacific Marine Hydroid Garveia annulata.
Ref 528499J Nat Prod. 2006 Oct;69(10):1496-9.Indoleamine 2,3-dioxygenase inhibitors from the Northeastern Pacific Marine Hydroid Garveia annulata.
Ref 528499J Nat Prod. 2006 Oct;69(10):1496-9.Indoleamine 2,3-dioxygenase inhibitors from the Northeastern Pacific Marine Hydroid Garveia annulata.
Ref 528499J Nat Prod. 2006 Oct;69(10):1496-9.Indoleamine 2,3-dioxygenase inhibitors from the Northeastern Pacific Marine Hydroid Garveia annulata.
Ref 528499J Nat Prod. 2006 Oct;69(10):1496-9.Indoleamine 2,3-dioxygenase inhibitors from the Northeastern Pacific Marine Hydroid Garveia annulata.
Ref 529353J Med Chem. 2008 Mar 27;51(6):1706-18. Epub 2008 Mar 5.Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.
Ref 529353J Med Chem. 2008 Mar 27;51(6):1706-18. Epub 2008 Mar 5.Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.
Ref 531087Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9. Epub 2010 Jul 11.S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.
Ref 528499J Nat Prod. 2006 Oct;69(10):1496-9.Indoleamine 2,3-dioxygenase inhibitors from the Northeastern Pacific Marine Hydroid Garveia annulata.
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.
Ref 531087Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9. Epub 2010 Jul 11.S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.
Ref 531087Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9. Epub 2010 Jul 11.S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Ref 531087Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9. Epub 2010 Jul 11.S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Ref 531087Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9. Epub 2010 Jul 11.S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.
Ref 531087Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9. Epub 2010 Jul 11.S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Ref 531087Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9. Epub 2010 Jul 11.S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Ref 529353J Med Chem. 2008 Mar 27;51(6):1706-18. Epub 2008 Mar 5.Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.
Ref 529619J Med Chem. 2008 Aug 28;51(16):4968-77. Epub 2008 Jul 30.Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.
Ref 529619J Med Chem. 2008 Aug 28;51(16):4968-77. Epub 2008 Jul 30.Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.
Ref 531087Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9. Epub 2010 Jul 11.S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.
Ref 531087Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9. Epub 2010 Jul 11.S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Ref 531087Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9. Epub 2010 Jul 11.S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Ref 531087Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9. Epub 2010 Jul 11.S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Ref 531087Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9. Epub 2010 Jul 11.S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Ref 531087Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9. Epub 2010 Jul 11.S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Ref 531087Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9. Epub 2010 Jul 11.S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Ref 531087Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9. Epub 2010 Jul 11.S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Ref 531087Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9. Epub 2010 Jul 11.S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Ref 531087Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9. Epub 2010 Jul 11.S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Ref 529405J Med Chem. 2008 May 8;51(9):2634-7. Epub 2008 Apr 8.Synthesis of indoleamine 2,3-dioxygenase inhibitory analogues of the sponge alkaloid exiguamine A.
Ref 529619J Med Chem. 2008 Aug 28;51(16):4968-77. Epub 2008 Jul 30.Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.
Ref 529619J Med Chem. 2008 Aug 28;51(16):4968-77. Epub 2008 Jul 30.Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.
Ref 528499J Nat Prod. 2006 Oct;69(10):1496-9.Indoleamine 2,3-dioxygenase inhibitors from the Northeastern Pacific Marine Hydroid Garveia annulata.
Ref 531087Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9. Epub 2010 Jul 11.S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Ref 529405J Med Chem. 2008 May 8;51(9):2634-7. Epub 2008 Apr 8.Synthesis of indoleamine 2,3-dioxygenase inhibitory analogues of the sponge alkaloid exiguamine A.
Ref 531087Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9. Epub 2010 Jul 11.S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Ref 529353J Med Chem. 2008 Mar 27;51(6):1706-18. Epub 2008 Mar 5.Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.
Ref 529619J Med Chem. 2008 Aug 28;51(16):4968-77. Epub 2008 Jul 30.Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.
Ref 527977J Med Chem. 2006 Jan 26;49(2):684-92.Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors.
Ref 528499J Nat Prod. 2006 Oct;69(10):1496-9.Indoleamine 2,3-dioxygenase inhibitors from the Northeastern Pacific Marine Hydroid Garveia annulata.
Ref 531087Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9. Epub 2010 Jul 11.S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Ref 530194J Med Chem. 2009 Dec 10;52(23):7364-7.Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model.
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.
Ref 529353J Med Chem. 2008 Mar 27;51(6):1706-18. Epub 2008 Mar 5.Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.
Ref 529353J Med Chem. 2008 Mar 27;51(6):1706-18. Epub 2008 Mar 5.Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.
Ref 528499J Nat Prod. 2006 Oct;69(10):1496-9.Indoleamine 2,3-dioxygenase inhibitors from the Northeastern Pacific Marine Hydroid Garveia annulata.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.